# IB Acquisition Corp.: overview IBAC · Nasdaq · CIK 1998781 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/ibac.md) · [Financials](/companies/ibac/financials.md) · [Filings](/companies/ibac/filings.md) · [Insiders](/companies/ibac/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ibac/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $220.3k | 20,436 | | Added +63 | | [Clear Street Group Inc.](/funds/1881567.md) | 2026-06-30 | $181.2k | 16,807 | | Added +1,807 | | [Wealthspring Capital LLC](/funds/1844495.md) | 2026-06-30 | $97.9k | 851,160 | | Reduced −7,859 | | [AQR Arbitrage LLC](/funds/1167456.md) | 2026-06-30 | $86.8k | 732,521 | | Unchanged | | [Polar Asset Management Partners Inc.](/funds/1326389.md) | 2026-06-30 | $57.5k | 500,000 | | Unchanged | | [BOOTHBAY FUND MANAGEMENT, LLC](/funds/1549230.md) | 2026-06-30 | $53.2k | 462,793 | | Reduced −94 | | [TORONTO DOMINION BANK](/funds/947263.md) | 2026-06-30 | $46.0k | 400,000 | | Reduced −100,000 | | [Westchester Capital Management, LLC](/funds/1512805.md) | 2026-06-30 | $41.4k | 349,019 | | Unchanged | | [Clear Street Group Inc.](/funds/1881567.md) | 2026-06-30 | $23.4k | 203,154 | | Unchanged | | [Context Capital Management, LLC](/funds/1301396.md) | 2026-06-30 | $23.0k | 200,000 | | Unchanged | ## Recent filings [All 84 filings](/companies/ibac/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 20:15 ET | [8-K](/filings/0001493152-26-047243.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047243 | | 2026-10-06 | 21:15 ET | [8-K](/filings/0001493152-26-045994.md) | 3.01 Delisting notice | 0001493152-26-045994 | | 2026-09-30 | 22:30 ET | [8-K](/filings/0001493152-26-044947.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-044947 | | 2026-09-23 | 21:15 ET | [8-K/A](/filings/0001493152-26-043952.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-043952 | | 2026-09-21 | 21:03 ET | [8-K](/filings/0001493152-26-043585.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-043585 | | 2026-09-04 | 20:05 ET | [DEF 14A](/filings/0001493152-26-041539.md) | Proxy statement, period 2026-09-04 | 0001493152-26-041539 | | 2026-08-14 | 14:20 ET | [10-Q](/filings/0001493152-26-038060.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038060 | | 2026-05-15 | 20:05 ET | [10-Q](/filings/0001493152-26-023743.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023743 | | 2026-03-27 | 20:23 ET | [8-K](/filings/0001493152-26-013210.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-013210 | | 2026-03-26 | 13:00 ET | [8-K](/filings/0001493152-26-012814.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-012814 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001493152-25-029365.md), filed Dec 29, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1998781 - Tickers: IBAC, IBACR - Exchange: Nasdaq - SIC code: 8731 Services-Commercial Physical & Biological Research - State of incorporation: NV - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.